Crossmark

Comparison of treatment patterns, efficacy and safety between generic and branded atorvastatin users in China: a multicenter, retrospective propensity score-matched cohort study

Crossref DOI link: https://doi.org/10.1186/s12944-025-02673-9

Published Online: 2025-07-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xing, Xiaoxuan

Wang, Zhizhou

Wang, Ke

Hua, Yiming

Li, Xiaoxi

Le, Kejia

Ma, Wenbing

Guan, Yingyun

Deng, Aiping

Yun, Xiong

Cai, Hongfu

Lyu, Yongning

Xiong, Guoying

Yang, Min

Wang, Siyang

Xue, Chaojun

Zhang, Jing

Guo, Qiushi

Hu, Song

Li, Jing

Dong, Xianzhe

Zhang, Lan
Funding

Funding for this research was provided by:

Wu Jieping Medical Foundation (320.6750.2023-06-81)
License Information

Text and Data Mining valid from 2025-07-22

Version of Record valid from 2025-07-22
More Information

Article History

Received: 10 January 2025

Accepted: 15 July 2025

First Online: 22 July 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below